These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33034273)

  • 1. Kinesin Family Member C1 (KIFC1) Accelerates Proliferation and Invasion of Endometrial Cancer Cells Through Modulating the PI3K/AKT Signaling Pathway.
    Zhou K; Zhao J; Qi L; He Y; Xu J; Dai M
    Technol Cancer Res Treat; 2020; 19():1533033820964217. PubMed ID: 33034273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIFC1 promotes aerobic glycolysis in endometrial cancer cells by regulating the c-myc pathway.
    Zhou K; Lin J; Dai M; He Y; Xu J; Lin Q
    J Bioenerg Biomembr; 2021 Dec; 53(6):703-713. PubMed ID: 34729671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDK1 promotes the phosphorylation of KIFC1 to regulate the tumorgenicity of endometrial carcinoma.
    Lin X; He Y; Liu Y; Zhou H; Xu X; Xu J; Zhou K
    J Gynecol Oncol; 2024 Sep; 35(5):e68. PubMed ID: 38456590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of synuclein gamma inhibits the movability of endometrial carcinoma cells by PI3K/AKT/ERK signaling pathway.
    Ni M; Zhao Y; Wang X
    Genes Genomics; 2021 Jun; 43(6):633-641. PubMed ID: 33788083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of SLCO4C1 inhibits cell proliferation and metastasis in endometrial cancer through inactivating the PI3K/Akt signaling pathway.
    Hu X; Han T; Bian Y; Tong H; Wen X; Li Y; Wan X
    Oncol Rep; 2020 Mar; 43(3):919-929. PubMed ID: 32020231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
    Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway.
    Wang Y; Yin L; Sun X
    J Exp Clin Cancer Res; 2020 Aug; 39(1):169. PubMed ID: 32847606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
    Zhang S; Wang M; Li Q; Zhu P
    Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling.
    Xiao KH; Teng K; Ye YL; Tan L; Chen MK; Liang HT; Feng ZH; Duan JL; Deng MH; Wei WS; Luo JH; Qin ZK; Xie D
    Cancer Sci; 2019 Sep; 110(9):2822-2833. PubMed ID: 31278883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway.
    Zhang XH; Li M; Kang YJ; Xie YQ; Cao YX
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6830-6838. PubMed ID: 31486482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRC5 promotes cell migration and invasion by activating the PI3K/AKT signaling pathway in endometrial cancer.
    Fan Y; Dong Z; Shi Y; Sun S; Wei B; Zhan L
    J Int Med Res; 2020 May; 48(5):300060520925352. PubMed ID: 32431202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway.
    Xu X; Kong X; Liu T; Zhou L; Wu J; Fu J; Wang Y; Zhu M; Yao S; Ding Y; Ding L; Li R; Zhu X; Tang X; Zhang Y; Yang Q; Ling J; Zhou H
    Gynecol Oncol; 2019 Jul; 154(1):207-217. PubMed ID: 30979588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway.
    Qiao L; Dong C; Ma B
    J Recept Signal Transduct Res; 2022 Apr; 42(2):151-159. PubMed ID: 33435787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA DLEU1 contributes to tumorigenesis and development of endometrial carcinoma by targeting mTOR.
    Du Y; Wang L; Chen S; Liu Y; Zhao Y
    Mol Carcinog; 2018 Sep; 57(9):1191-1200. PubMed ID: 29745433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR‑494‑3p promotes the progression of endometrial cancer by regulating the PTEN/PI3K/AKT pathway.
    Zhu L; Wang X; Wang T; Zhu W; Zhou X
    Mol Med Rep; 2019 Jan; 19(1):581-588. PubMed ID: 30431102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinesin Motor Protein KIFC1 Is a Target Protein of miR-338-3p and Is Associated With Poor Prognosis and Progression of Renal Cell Carcinoma.
    Li G; Chong T; Yang J; Li H; Chen H
    Oncol Res; 2018 Dec; 27(1):125-137. PubMed ID: 29562961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity.
    Teng K; Wei S; Zhang C; Chen J; Chen J; Xiao K; Liu J; Dai M; Guan X; Yun J; Xie D
    J Exp Clin Cancer Res; 2019 Jul; 38(1):329. PubMed ID: 31340839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinesin Family Member C1 Overexpression Exerts Tumor-Promoting Properties in Head and Neck Squamous Cell Carcinoma via the Rac1/Wnt/β-catenin Pathway.
    Yu BY; Shi LG; Jiang C; Wang GK; Liu J; Wu TY
    Lab Invest; 2023 Jul; 103(7):100134. PubMed ID: 36990154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-210-3p accelerates tumor-relevant cell functions of endometrial carcinoma by repressing RUNX1T1.
    Dai Z; Luo H; Chen J; Li L
    Mutat Res; 2022; 825():111793. PubMed ID: 35963185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A.
    Yang Y; Wu J; Zhou H; Liu W; Wang J; Zhang Q
    Cell Cycle; 2020 Jun; 19(12):1502-1516. PubMed ID: 32401659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.